{"id":"W4400412464","doi":"10.1200/jco.2024.42.16_suppl.e17030","title":"Association of baseline characteristics with adverse events (AEs) in the PROpel trial of olaparib (ola) plus abiraterone (abi) as first-line (1L) treatment for metastatic castration-resistant prostate cancer (mCRPC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Olaparib; Abiraterone; Internal medicine; Adverse effect; Oncology; Abiraterone acetate; Cancer; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002630349,0.0002635512,0.0005520784,0.000260149,0.0001572333,0.0005916872,0.0002876823,0.0005495994,0.001954962],"category_scores_gemma":[0.003521904,0.0001621811,0.0007356198,0.0004594355,0.0002160734,0.0004194623,0.0003196704,0.000908875,0.0001936839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002786969,"about_ca_system_score_gemma":0.0003675584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002939594,"about_ca_topic_score_gemma":0.0009299319,"domain_scores_codex":[0.9990423,0.000483382,0.00007454026,0.0001490276,0.0001447704,0.0001058248],"domain_scores_gemma":[0.9967783,0.00135921,0.001238441,0.0001266559,0.0001369262,0.0003605709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2444813,0.001380695,0.7168118,0.0008274994,0.003946064,0.0002921821,0.0001337855,0.0009975666,0.002178268,0.0001165562,0.002375324,0.02645889],"study_design_scores_gemma":[0.008556372,0.02152922,0.9641259,0.00008180978,0.001425653,0.0004334693,0.00007734758,0.001373274,0.0006096177,0.0001729907,0.001578768,0.00003557926],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963625,0.001762022,0.0001194699,0.00008008791,0.00002552217,0.00008166314,0.001079505,0.000006936919,0.0004823566],"genre_scores_gemma":[0.997921,0.0002315523,0.0001066251,0.00007794855,0.00003448262,0.00009746887,0.001259414,0.000002958592,0.0002685131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002630349,"threshold_uncertainty_score":0.01391083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1564634287532937,"score_gpt":0.4899003302968871,"score_spread":0.3334369015435933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}